Alternative vaccines for adults aged 30 and 30 to 39 for coronavirus (COVID-19)

Alternative vaccines for adults aged 30 and 30 to 39 for coronavirus (COVID-19)

The Department of Health and Social Care (DHSC) has published a statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the extremely rare cases of thrombosis (blood clots) and thrombocytopenia (low platelet count) following a first dose of the AstraZeneca coronavirus (COVID-19) vaccine. JCVI has advised, following consideration of benefits and risks, that adults under 30 and adults aged 30 to 39 without underlying health conditions should have a preference for an alternative vaccine to the AstraZeneca one, if available and if it does not cause delays in being vaccinated.

Source:

• Independent report: Use of the AstraZeneca COVID-19 vaccine: JCVI statement, 7 May 2021

• JCVI advises on COVID-19 vaccine for people aged under 40

• Statement on AstraZeneca COVID-19 vaccine following JCVI update

• MHRA response to JCVI advice on COVID-19 Vaccine AstraZeneca for people aged under 40

• Welsh Government update – AstraZeneca Vaccine

Related Articles:
Latest Articles: